查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612798

心律不整监测设备市场：按设备、最终用户划分 - 2025-2030 年全球预测

Cardiac Arrhythmia Monitoring Devices Market by Device (Electrocardiogram Monitor, Event Recorder, Holter Monitor), End-User (Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心律不整监测设备市值为87.6亿美元，预计2024年将达到94.4亿美元，复合年增长率为8.03%，预计到2030年将达到150.6亿美元。

心律不整监测设备对于心律不整的诊断和管理至关重要，可为治疗和预防策略提供见解。该领域涉及连续、即时的资料收集和分析，这对于心臟疾病的及时诊断和有效管理至关重要。由于全球心臟相关疾病的盛行率不断上升，加上人口老化需要先进的医疗保健解决方案，对此类设备的需求不断增加。应用包括医院环境、门诊护理中心和家庭场景，以增强传统临床环境以外的病患监测。典型的最终用户包括医疗保健专业人员、心臟病诊所和寻求自我监测的技术力的患者。

主要市场统计
基准年[2023] 87.6亿美元
预测年份 [2024] 94.4亿美元
预测年份 [2030] 150.6亿美元
复合年增长率（%） 8.03%

市场成长的推动因素包括穿戴式和无线设备等技术进步、预防性医疗保健意识的提高以及政府鼓励数位医疗保健解决方案的支持措施。与人工智慧和机器学习的连接和整合进行预测分析为提高诊断准确性和个人化患者照护提供了重要机会。为了利用这些趋势，鼓励公司投资开发用户友好的介面和资料隐私的安全系统。然而，挑战包括高昂的设备成本、严格的法律规范和有限的报销方案，阻碍了广泛采用。

最大限度地发挥成长潜力需要专注于提高设备精度、延长电池寿命和小型化以提高患者舒适度和依从性的创新。解决这些技术障碍可以为市场采用提供巨大动力。此外，与高科技公司和研究机构的策略联盟可以加快新设备的开发和核准过程。总体而言，心律不整监测设备市场仍然充满活力，需要持续创新，以在监管和经济挑战的背景下抓住新机会，帮助企业保持竞争力，并且必须能够跟上技术进步的步伐。

市场动态：快速发展的心律不整监测设备市场的关键市场洞察

心律不整监测设备市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球心血管疾病盛行率不断上升
    • 越来越关注远端监控和远端医疗
    • 消费者越来越多地采用穿戴式健康技术
  • 市场限制因素
    • 开发心律不整监测设备成本高昂
  • 市场机会
    • 心律不整监测设备的进展
    • 心血管疾病治疗的政府报销计划和政策
  • 市场挑战
    • 心律不整监测设备的限制与故障问题

波特五力：驾驭心律不整监测设备市场的策略工具

波特的五力架构是了解心律不整监测设备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心律不整监测设备市场的外部影响

外部宏观环境因素在塑造心律不整监测设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心律不整监测设备市场的竞争格局

心律不整监测设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心律不整监测设备市场供应商的绩效评估

FPNV定位矩阵是评估心律不整监测设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划心律不整监测设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心律不整监测设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球心血管疾病盛行率增加
      • 人们对远距监控和远端医疗的兴趣日益浓厚
      • 消费者越来越多地采用穿戴式健康技术
    • 抑制因素
      • 心律不整监测设备研发成本高
    • 机会
      • 心律不整监测设备的进展
      • 心血管疾病治疗的政府报销计划和政策
    • 任务
      • 心律不整监测设备的限制与故障问题
  • 市场区隔分析
    • 设备：越来越多地采用心电图监视器来检测心动週期每个阶段的持续时间和时间
    • 最终用户：在优先考虑高精度设备的诊断中心中增加使用心律不整监测设备
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心律不整监测设备市场：依设备分类

  • 心电图监视器
  • 事件记录器
  • 心电图监测
  • 植入式心臟监测仪
  • 移动心电遥测

第七章心律不整监测设备市场：依最终使用者分类

  • 门诊手术中心
  • 诊断中心
  • 家庭护理设置
  • 医院/诊所

第八章美洲心律不整监测设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太心律不整监测设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲心律不整监测设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准下一代人工智慧心电图监测设备
    • FDA核准用于长期心律不整监测的下一代可插入装置
    • UltraLinQ 在阿拉伯健康中心推出新型心臟监测产品
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACS Diagnostics, Inc.
  • AliveCor, Inc.
  • Aspel SA
  • BIOTRONIK SE & CO., KG
  • BORSAM Biomedical Instruments Co., Ltd.
  • Boston Scientific Corporation
  • custo med GmbH
  • GE HealthCare Technologies, Inc.
  • Hillrom Services, Inc. by Baxter International Inc.
  • InfoBionic
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Norav Medical Inc.
  • OSI Systems, Inc.
  • SCHILLER
  • SmartCardia SA
  • Stryker Corporation
  • UltraLinQ Healthcare Solutions, Inc.
  • Viatom Technology Co., Ltd.
  • ZOLL Medical Corporation by Asahi Kasei Corporation
Product Code: MRR-450A0628CC43

The Cardiac Arrhythmia Monitoring Devices Market was valued at USD 8.76 billion in 2023, expected to reach USD 9.44 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 15.06 billion by 2030.

Cardiac arrhythmia monitoring devices are critical in diagnosing and managing irregular heartbeats, offering insights for treatment and prevention strategies. The scope involves continuous and real-time data capture and analysis, crucial for timely diagnosis and effective management of cardiac conditions. There is a necessity for such devices given the rising prevalence of heart-related ailments globally, coupled with an aging population that demands advanced healthcare solutions. Applications include hospital settings, ambulatory care centers, and home-use scenarios, enhancing patient monitoring outside traditional clinical environments. Key end-users span healthcare professionals, cardiology clinics, and technologically-enabled patients aiming for self-monitoring.

KEY MARKET STATISTICS
Base Year [2023] USD 8.76 billion
Estimated Year [2024] USD 9.44 billion
Forecast Year [2030] USD 15.06 billion
CAGR (%) 8.03%

Market growth is driven by technological advancements, like wearable and wireless devices, increasing awareness of preventive healthcare, and supportive government initiatives that encourage digital healthcare solutions. Connectivity and integration with AI and machine learning for predictive analytics present significant opportunities, as they enhance diagnostic accuracy and personalized patient care. To capitalize on these trends, businesses are advised to invest in the development of user-friendly interfaces and secure systems for data privacy. However, challenging factors include high device costs, stringent regulatory frameworks, and limited reimbursement scenarios that hinder widespread adoption.

For maximum growth potential, innovation must focus on enhancing device accuracy, extending battery life, and improving miniaturization to increase patient comfort and compliance. Addressing these technological hurdles can spur market adoption significantly. Furthermore, strategic collaborations with tech companies and research institutions could accelerate the development and approval processes of new devices. Overall, the cardiac arrhythmia monitoring device market remains dynamic, with continuous innovation necessary for capturing emerging opportunities against a backdrop of regulatory and economic challenges, ensuring companies stay competitive and aligned with healthcare advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Arrhythmia Monitoring Devices Market

The Cardiac Arrhythmia Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular disorders worldwide
    • Growing inclination towards remote monitoring and telemedicine
    • Rising adoption of wearable health technologies by consumers
  • Market Restraints
    • High cost of development of cardiac arrhythmia monitoring devices
  • Market Opportunities
    • Advancements in cardiac arrhythmia monitoring devices
    • Government reimbursement programs and policies for cardiovascular disease treatment
  • Market Challenges
    • Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Arrhythmia Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Arrhythmia Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Arrhythmia Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Arrhythmia Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Arrhythmia Monitoring Devices Market

A detailed market share analysis in the Cardiac Arrhythmia Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Arrhythmia Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Arrhythmia Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Arrhythmia Monitoring Devices Market

A strategic analysis of the Cardiac Arrhythmia Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrhythmia Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Inc., AliveCor, Inc., Aspel SA, BIOTRONIK SE & CO., KG, BORSAM Biomedical Instruments Co., Ltd., Boston Scientific Corporation, custo med GmbH, GE HealthCare Technologies, Inc., Hillrom Services, Inc. by Baxter International Inc., InfoBionic, iRhythm Technologies, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Nihon Kohden Corporation, Norav Medical Inc., OSI Systems, Inc., SCHILLER, SmartCardia SA, Stryker Corporation, UltraLinQ Healthcare Solutions, Inc., Viatom Technology Co., Ltd., and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrhythmia Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Electrocardiogram Monitor, Event Recorder, Holter Monitor, Implantable Cardiac Monitor, and Mobile Cardiac Telemetry.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular disorders worldwide
      • 5.1.1.2. Growing inclination towards remote monitoring and telemedicine
      • 5.1.1.3. Rising adoption of wearable health technologies by consumers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of cardiac arrhythmia monitoring devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in cardiac arrhythmia monitoring devices
      • 5.1.3.2. Government reimbursement programs and policies for cardiovascular disease treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device: Growing adoption of electrocardiogram monitors for detecting the duration and timing of each phase in the heart's cycle
    • 5.2.2. End-User: Growing usage of cardiac arrhythmia monitoring devices across diagnostic centers that prioritize high-precision devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Arrhythmia Monitoring Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Electrocardiogram Monitor
  • 6.3. Event Recorder
  • 6.4. Holter Monitor
  • 6.5. Implantable Cardiac Monitor
  • 6.6. Mobile Cardiac Telemetry

7. Cardiac Arrhythmia Monitoring Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Diagnostic Centers
  • 7.4. Homecare Settings
  • 7.5. Hospitals & Clinics

8. Americas Cardiac Arrhythmia Monitoring Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FDA clears next-generation AI-powered ECG monitoring device
    • 11.3.2. FDA clears next-generation insertable device for long-term arrhythmia monitoring
    • 11.3.3. UltraLinQ to launch new cardiac monitoring product at Arab Health
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics, Inc.
  • 3. AliveCor, Inc.
  • 4. Aspel SA
  • 5. BIOTRONIK SE & CO., KG
  • 6. BORSAM Biomedical Instruments Co., Ltd.
  • 7. Boston Scientific Corporation
  • 8. custo med GmbH
  • 9. GE HealthCare Technologies, Inc.
  • 10. Hillrom Services, Inc. by Baxter International Inc.
  • 11. InfoBionic
  • 12. iRhythm Technologies, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 15. Medtronic PLC
  • 16. Nihon Kohden Corporation
  • 17. Norav Medical Inc.
  • 18. OSI Systems, Inc.
  • 19. SCHILLER
  • 20. SmartCardia SA
  • 21. Stryker Corporation
  • 22. UltraLinQ Healthcare Solutions, Inc.
  • 23. Viatom Technology Co., Ltd.
  • 24. ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY EVENT RECORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY MOBILE CARDIAC TELEMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023